AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters

Apolipoprotein C2 (ApoC2) is a key activator of lipoprotein lipase for plasma triglyceride metabolism. ApoC2-deficient patients present with severe hypertriglyceridemia and recurrent acute pancreatitis, for whom the only effective treatment is the infusion of normal plasma containing ApoC2. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chun, Tian, Wenhong, Ma, Sisi, Guo, Mengmeng, Lin, Xiao, Gao, Fengying, Dong, Xiaoyan, Gao, Mingming, Wang, Yuhui, Liu, George, Xian, Xunde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424175/
https://www.ncbi.nlm.nih.gov/pubmed/32802915
http://dx.doi.org/10.1016/j.omtm.2020.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424175/
https://www.ncbi.nlm.nih.gov/pubmed/32802915
http://dx.doi.org/10.1016/j.omtm.2020.07.011

Ejemplares similares